EMEA (Europe, Middle East and Africa) Lenalidomide Market Report 2017

December 2017 | 102 pages | ID: E01A597E3E9EN
QYResearch

Abstracts

In this report, the EMEA Lenalidomide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Lenalidomide for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Lenalidomide market competition by top manufacturers/players, with Lenalidomide sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Takeda Canada Inc
• Celgene

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 5 mg Capsules
• 10 mg Capsules
• 15 mg Capsules
• 25 mg Capsules

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer
• Cardiovascular Disease
• Immune Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Lenalidomide Market Report 2017

1 LENALIDOMIDE OVERVIEW

1.1 Product Overview and Scope of Lenalidomide
1.2 Classification of Lenalidomide
  1.2.1 EMEA Lenalidomide Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Lenalidomide Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 5 mg Capsules
  1.2.4 10 mg Capsules
  1.2.5 15 mg Capsules
  1.2.6 25 mg Capsules
1.3 EMEA Lenalidomide Market by Application/End Users
  1.3.1 EMEA Lenalidomide Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cancer
  1.3.3 Cardiovascular Disease
  1.3.4 Immune Disease
1.4 EMEA Lenalidomide Market by Region
  1.4.1 EMEA Lenalidomide Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Lenalidomide (2012-2022)
  1.5.1 EMEA Lenalidomide Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Lenalidomide Revenue and Growth Rate (2012-2022)

2 EMEA LENALIDOMIDE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Lenalidomide Market Competition by Players/Manufacturers
  2.1.1 EMEA Lenalidomide Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Lenalidomide Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Lenalidomide Sale Price by Players (2012-2017)
2.2 EMEA Lenalidomide (Volume and Value) by Type/Product Category
  2.2.1 EMEA Lenalidomide Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Lenalidomide Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Lenalidomide Sale Price by Type (2012-2017)
2.3 EMEA Lenalidomide (Volume) by Application
2.4 EMEA Lenalidomide (Volume and Value) by Region
  2.4.1 EMEA Lenalidomide Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Lenalidomide Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Lenalidomide Sales Price by Region (2012-2017)

3 EUROPE LENALIDOMIDE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Lenalidomide Sales and Value (2012-2017)
  3.1.1 Europe Lenalidomide Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Lenalidomide Revenue and Growth Rate (2012-2017)
3.2 Europe Lenalidomide Sales and Market Share by Type
3.3 Europe Lenalidomide Sales and Market Share by Application
3.4 Europe Lenalidomide Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Lenalidomide Sales Volume by Countries (2012-2017)
  3.4.2 Europe Lenalidomide Revenue by Countries (2012-2017)
  3.4.3 Germany Lenalidomide Sales and Growth Rate (2012-2017)
  3.4.4 France Lenalidomide Sales and Growth Rate (2012-2017)
  3.4.5 UK Lenalidomide Sales and Growth Rate (2012-2017)
  3.4.6 Russia Lenalidomide Sales and Growth Rate (2012-2017)
  3.4.7 Italy Lenalidomide Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Lenalidomide Sales and Growth Rate (2012-2017)

4 MIDDLE EAST LENALIDOMIDE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Lenalidomide Sales and Value (2012-2017)
  4.1.1 Middle East Lenalidomide Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Lenalidomide Revenue and Growth Rate (2012-2017)
4.2 Middle East Lenalidomide Sales and Market Share by Type
4.3 Middle East Lenalidomide Sales and Market Share by Application
4.4 Middle East Lenalidomide Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Lenalidomide Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Lenalidomide Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Lenalidomide Sales and Growth Rate (2012-2017)
  4.4.4 Israel Lenalidomide Sales and Growth Rate (2012-2017)
  4.4.5 UAE Lenalidomide Sales and Growth Rate (2012-2017)
  4.4.6 Iran Lenalidomide Sales and Growth Rate (2012-2017)

5 AFRICA LENALIDOMIDE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Lenalidomide Sales and Value (2012-2017)
  5.1.1 Africa Lenalidomide Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Lenalidomide Revenue and Growth Rate (2012-2017)
5.2 Africa Lenalidomide Sales and Market Share by Type
5.3 Africa Lenalidomide Sales and Market Share by Application
5.4 Africa Lenalidomide Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Lenalidomide Sales Volume by Countries (2012-2017)
  5.4.2 Africa Lenalidomide Revenue by Countries (2012-2017)
  5.4.3 South Africa Lenalidomide Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Lenalidomide Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Lenalidomide Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Lenalidomide Sales and Growth Rate (2012-2017)

6 EMEA LENALIDOMIDE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Takeda Canada Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lenalidomide Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Takeda Canada Inc Lenalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Celgene
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Lenalidomide Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Celgene Lenalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview

7 LENALIDOMIDE MANUFACTURING COST ANALYSIS

7.1 Lenalidomide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lenalidomide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lenalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lenalidomide Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA LENALIDOMIDE MARKET FORECAST (2017-2022)

11.1 EMEA Lenalidomide Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Lenalidomide Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Lenalidomide Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Lenalidomide Price and Trend Forecast (2017-2022)
11.2 EMEA Lenalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Lenalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Lenalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Lenalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Lenalidomide Sales Forecast by Type (2017-2022)
11.7 EMEA Lenalidomide Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lenalidomide
Figure EMEA Lenalidomide Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Lenalidomide Sales Volume Market Share by Type (Product Category) in 2016
Figure 5 mg Capsules Product Picture
Figure 10 mg Capsules Product Picture
Figure 15 mg Capsules Product Picture
Figure 25 mg Capsules Product Picture
Figure EMEA Lenalidomide Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Lenalidomide by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure Immune Disease Examples
Table Key Downstream Customer in Immune Disease
Figure EMEA Lenalidomide Market Size (Million USD) by Region (2012-2022)
Figure Europe Lenalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Lenalidomide Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Lenalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Lenalidomide Revenue (Million USD) Status and Forecast by Countries
Figure Africa Lenalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Lenalidomide Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Lenalidomide Sales Volume and Growth Rate (2012-2022)
Figure EMEA Lenalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Lenalidomide Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Lenalidomide Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Lenalidomide Sales Share by Players (2012-2017)
Figure 2016 Lenalidomide Sales Share by Players
Figure 2017 Lenalidomide Sales Share by Players
Figure EMEA Lenalidomide Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Lenalidomide Revenue (Million USD) by Players (2012-2017)
Table EMEA Lenalidomide Revenue Share by Players (2012-2017)
Table 2016 EMEA Lenalidomide Revenue Share by Players
Table 2017 EMEA Lenalidomide Revenue Share by Players
Table EMEA Lenalidomide Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Lenalidomide Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Lenalidomide Sales Share by Type (2012-2017)
Figure Sales Market Share of Lenalidomide by Type (2012-2017)
Figure EMEA Lenalidomide Sales Market Share by Type (2012-2017)
Table EMEA Lenalidomide Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Lenalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lenalidomide by Type in 2016
Table EMEA Lenalidomide Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Lenalidomide Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Lenalidomide Sales Share by Application (2012-2017)
Figure Sales Market Share of Lenalidomide by Application (2012-2017)
Figure EMEA Lenalidomide Sales Market Share by Application in 2016
Table EMEA Lenalidomide Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Lenalidomide Sales Share by Region (2012-2017)
Figure Sales Market Share of Lenalidomide by Region (2012-2017)
Figure EMEA Lenalidomide Sales Market Share in 2016
Table EMEA Lenalidomide Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Lenalidomide Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Lenalidomide by Region (2012-2017)
Figure EMEA Lenalidomide Revenue Market Share Regions in 2016
Table EMEA Lenalidomide Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Lenalidomide Revenue and Growth Rate (2012-2017)
Table Europe Lenalidomide Sales (K MT) by Type (2012-2017)
Table Europe Lenalidomide Market Share by Type (2012-2017)
Figure Europe Lenalidomide Market Share by Type in 2016
Table Europe Lenalidomide Sales (K MT) by Application (2012-2017)
Table Europe Lenalidomide Market Share by Application (2012-2017)
Figure Europe Lenalidomide Market Share by Application in 2016
Table Europe Lenalidomide Sales (K MT) by Countries (2012-2017)
Table Europe Lenalidomide Sales Market Share by Countries (2012-2017)
Figure Europe Lenalidomide Sales Market Share by Countries (2012-2017)
Figure Europe Lenalidomide Sales Market Share by Countries in 2016
Table Europe Lenalidomide Revenue (Million USD) by Countries (2012-2017)
Table Europe Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Europe Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Europe Lenalidomide Revenue Market Share by Countries in 2016
Figure Germany Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure France Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure UK Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Lenalidomide Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Lenalidomide Sales (K MT) by Type (2012-2017)
Table Middle East Lenalidomide Market Share by Type (2012-2017)
Figure Middle East Lenalidomide Market Share by Type (2012-2017)
Table Middle East Lenalidomide Sales (K MT) by Applications (2012-2017)
Table Middle East Lenalidomide Market Share by Applications (2012-2017)
Figure Middle East Lenalidomide Sales Market Share by Application in 2016
Table Middle East Lenalidomide Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Lenalidomide Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Lenalidomide Sales Volume Market Share by Countries in 2016
Table Middle East Lenalidomide Revenue (Million USD) by Countries (2012-2017)
Table Middle East Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Middle East Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Middle East Lenalidomide Revenue Market Share by Countries in 2016
Figure Saudi Arabia Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Lenalidomide Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Lenalidomide Sales (K MT) by Type (2012-2017)
Table Africa Lenalidomide Sales Market Share by Type (2012-2017)
Figure Africa Lenalidomide Sales Market Share by Type (2012-2017)
Figure Africa Lenalidomide Sales Market Share by Type in 2016
Table Africa Lenalidomide Sales (K MT) by Application (2012-2017)
Table Africa Lenalidomide Sales Market Share by Application (2012-2017)
Figure Africa Lenalidomide Sales Market Share by Application (2012-2017)
Table Africa Lenalidomide Sales Volume (K MT) by Countries (2012-2017)
Table Africa Lenalidomide Sales Market Share by Countries (2012-2017)
Figure Africa Lenalidomide Sales Market Share by Countries (2012-2017)
Figure Africa Lenalidomide Sales Market Share by Countries in 2016
Table Africa Lenalidomide Revenue (Million USD) by Countries (2012-2017)
Table Africa Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Africa Lenalidomide Revenue Market Share by Countries (2012-2017)
Figure Africa Lenalidomide Revenue Market Share by Countries in 2016
Figure South Africa Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Table Takeda Canada Inc Lenalidomide Basic Information List
Table Takeda Canada Inc Lenalidomide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Takeda Canada Inc Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Takeda Canada Inc Lenalidomide Sales Market Share in EMEA (2012-2017)
Figure Takeda Canada Inc Lenalidomide Revenue Market Share in EMEA (2012-2017)
Table Celgene Lenalidomide Basic Information List
Table Celgene Lenalidomide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Lenalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Celgene Lenalidomide Sales Market Share in EMEA (2012-2017)
Figure Celgene Lenalidomide Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lenalidomide
Figure Manufacturing Process Analysis of Lenalidomide
Figure Lenalidomide Industrial Chain Analysis
Table Raw Materials Sources of Lenalidomide Major Manufacturers in 2016
Table Major Buyers of Lenalidomide
Table Distributors/Traders List
Figure EMEA Lenalidomide Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Lenalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Lenalidomide Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Lenalidomide Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Lenalidomide Sales Market Share Forecast by Region (2017-2022)
Table EMEA Lenalidomide Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Lenalidomide Revenue Market Share Forecast by Region (2017-2022)
Table Europe Lenalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Lenalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Europe Lenalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Lenalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Lenalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Lenalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Lenalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Lenalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Lenalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Lenalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Africa Lenalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Lenalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Lenalidomide Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Lenalidomide Sales Market Share Forecast by Type (2017-2022)
Table EMEA Lenalidomide Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Lenalidomide Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources